ReGen Biologics, Inc. · Franklin Lakes, NJ United States (OTC: RGBI)
| 509 Commerce St., 1st Fl., E. Wing | Phone: 201-651-5140 |
| Franklin Lakes, NJ | Fax: 201-651-5141 |
| 07417 | |
| United States | 
Map This Company |
ReGen Biologics, Inc. Rankings
More Companies in These Related Industries: Electromedical Apparatus MfgCompany Description
Injured athletes in need of tissue can dry their eyes thanks to ReGen Biologics. The company makes tissue implants and medical devices that are used to repair damaged or degenerating cartilage. ReGen's product line focuses on the repair and preservation of the meniscus, a piece of cartilage found in the knees. The company makes Menaflex, a collagen matrix product designed to halt deterioration, support natural regrowth of tissue, restore function, and reduce pain; the implant is approved for sale in parts of Europe and Africa. However, its US approval was rescinded following an investigation into the FDA approval process. ReGen filed for bankruptcy protection shortly after the rescission in 2011.
ReGen Biologics, Inc. Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public - OTC: RGBI Headquarters |
|---|---|
| Fiscal Year-End | December |
| Employees | 20 |
Executives
10 executives listed for ReGen Biologics, Inc. 's Franklin Lakes, NJ location.
| Chairman, President, CEO, and CFO | Gerald Bisbee | |
|---|---|---|
| SVP Clinical and Regulatory Affairs and Quality Assurance | John Dichiara | |
| SVP Administration | James Flounlacker |